Press releases

Non Regulatory

December 10, 2021

Inceptua receives formal approval of the transfer of Oasmia’s marketing authorization for Apealea®

Non Regulatory

November 26, 2021

Oasmia to present at Stora Aktiedagen Stockholm on December 2

Non Regulatory

November 26, 2021

Oasmia to present at the Erik Penser Bank Life Science Day on December 2

Non Regulatory

November 11, 2021

Invitation to presentation of Oasmia’s Q3 report on November 18

Non Regulatory

September 24, 2021

Oasmia to present at Naventus Life Science Summit on September 29

Non Regulatory

September 17, 2021

Oasmia signs agreement with FarmaMondo to commercialize Paclical® in Russia & CIS

Non Regulatory

August 31, 2021

Oasmia to present at Aktiedagen Stockholm on September 7

Non Regulatory

August 26, 2021

Oasmia strengthens internal capabilities with the appointments of Head of Clinical Development & Head of Regulatory Affairs

Non Regulatory

August 10, 2021

Invitation to presentation of Oasmia’s Q2 report on August 19

Non Regulatory

June 30, 2021

Cantrixil positive Phase I trial data published in the journal Cancers

Non Regulatory

June 28, 2021

Oasmia transfers Nordic commercialization rights for Apealea® to Inceptua

Non Regulatory

June 10, 2021

First Patient enrolled in the SAKK Investigator-Initiated Phase 1b trial of Docetaxel Micellar in Advanced Prostate Cancer

Non Regulatory

June 9, 2021

Oasmia Provides a R&D Update on its Technology Platforms

Non Regulatory

June 2, 2021

Oasmia to present at Aktiespararna’s Småbolagsdagar on June 9

Non Regulatory

April 21, 2021

Phase 1b Trial of Oasmia’s Docetaxel Micellar in Advanced Prostate Cancer is Granted Ethical Committee Approval and can be Initiated

Non Regulatory

April 12, 2021

Oasmia Presents Cantrixil Final Phase I Data at the 2021 AACR Annual Meeting

Non Regulatory

April 1, 2021

Oasmia Pharmaceutical Appoints Dr Reinhard Koenig as Chief Scientific Officer

Non Regulatory

March 26, 2021

Oasmia to Present Cantrixil Final Phase I Data at the 2021 AACR Virtual Annual Meeting

Non Regulatory

March 24, 2021

European Patent Office Informs Oasmia of its Intention to Grant XMeNa Patent

Non Regulatory

March 3, 2021

Oasmia and Karolinska Institutet to collaborate on the biological potential of Oasmia’s proprietary drug delivery platform

Non Regulatory

February 16, 2021

Invitation to presentation of Oasmia’s Year-end report on February 19

Non Regulatory

January 29, 2021

Oasmia Pharmaceutical Appoints Dr. Heidi B. Ramstad as Chief Medical Officer